These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3203165)

  • 21. Modulation of dopamine receptor sensitivity by estrogen.
    Gordon JH; Borison RL; Diamond BI
    Biol Psychiatry; 1980 Jun; 15(3):389-96. PubMed ID: 7189674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the estrous cycle and estradiol on the behavioral effects of amphetamine and apomorphine in rats.
    Díaz-Véliz G; Baeza R; Benavente F; Dussaubat N; Mora S
    Pharmacol Biochem Behav; 1994 Dec; 49(4):819-25. PubMed ID: 7886093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues.
    Waddington JL; Gamble SJ
    Psychopharmacology (Berl); 1980; 71(1):75-7. PubMed ID: 6779327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apomorphine-induced behaviour during the oestrous cycle of the rat.
    Kazandjian A; Spyraki C; Sfikakis A; Varonos DD
    Neuropharmacology; 1987 Aug; 26(8):1037-45. PubMed ID: 3658116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of estrogen and progesterone on behavioral effects of apomorphine and amphetamine.
    Michanek A; Meyerson BJ
    Pharmacol Biochem Behav; 1982 Jun; 16(6):875-9. PubMed ID: 7202216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of manipulation of the GABA system on dopamine-related behaviors.
    Sandoval MR; Palermo-Neto J
    Braz J Med Biol Res; 1995 Jan; 28(1):88-99. PubMed ID: 7581034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
    Timar J; Knoll B; Knoll J
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):255-66. PubMed ID: 3103558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of the intracaudate administration of kainic acid on the effects of the prolonged use of haloperidol and apomorphine on rats].
    Zharkovskiĭ AM; Allikmets LKh; Nurk AM
    Farmakol Toksikol; 1982; 45(1):10-2. PubMed ID: 7198997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged antidopaminergic actions of single doses of butyrophenones in the rat.
    Campbell A; Baldessarini RJ; Teicher MH; Kula NS
    Psychopharmacology (Berl); 1985; 87(2):161-6. PubMed ID: 3931140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats.
    Frussa-Filho R; Palermo-Neto J
    Physiol Behav; 1991 Oct; 50(4):825-30. PubMed ID: 1775558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a Palicourea marcgravii leaf extract on some dopamine-related behaviors of rats.
    Górniak SL; Palermo-Neto J; de Souza-Spinosa H
    J Ethnopharmacol; 1990 Mar; 28(3):329-35. PubMed ID: 2335961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist.
    Dias FR; de Matos LW; Sampaio Mde F; Carey RJ; Carrera MP
    Behav Brain Res; 2012 Apr; 229(1):153-9. PubMed ID: 22244923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic supersensitivity after long-term bromopride treatment.
    Felicio LF; Nasello AG; Palermo-Neto J
    Physiol Behav; 1987; 41(5):433-7. PubMed ID: 3432396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics.
    Fields JZ; Gordon JH
    Life Sci; 1982 Jan; 30(3):229-34. PubMed ID: 7200183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.